首页> 美国卫生研究院文献>Open Forum Infectious Diseases >1266. Characterization of Shifts in Minimum Inhibitory Concentrations During Treatment with Cefiderocol or Comparators in the Phase 3 CREDIBLE-CR and APEKS-NP Studies

【2h】

1266. Characterization of Shifts in Minimum Inhibitory Concentrations During Treatment with Cefiderocol or Comparators in the Phase 3 CREDIBLE-CR and APEKS-NP Studies

机译：1266.在第3阶段可信-CR和APEK-NP研究中使用Cefiderocol或比较剂治疗期间最小抑制浓度变化的表征

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Cefiderocol (CFDC) is a novel siderophore cephalosporin developed to treat serious carbapenem-resistant (CR) Gram-negative (GN) infections.

机译：Cefiderocol（CFDC）是一种新型的西参孢菌素，用于治疗严重的鲤鱼抗性（Cr）革兰阴性（GN）感染。

著录项

期刊名称 Open Forum Infectious Diseases
作者
Miki Takemura; Yoshinori Yamano; Yuko Matsunaga; Mari Ariyasu; Roger Echols; Tsutae Den Nagata;
展开▼
作者单位

展开▼
年(卷),期 2020(7),Suppl 1
年度 2020
页码 S649–S650
总页数 2
原文格式 PDF
正文语种
中图分类病毒传染病;
关键词

相似文献

外文文献
中文文献
专利

1. A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations – results of a prematurely terminated study [J] . Shirin Kalimuddin, Yvonne F. Z. Chan, Rachel Phillips, Trials . 2018,第1期

机译：万古霉素与达托霉素的随机2B期临床试验，用于治疗耐甲氧西林的金黄色葡萄球菌菌血症，因为该菌株具有高的万古霉素最低抑菌浓度–一项过早终止的研究结果
2. Vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations: study protocol for a phase IIB randomized controlled trial [J] . Shirin Kalimuddin, Rachel Phillips, Mihir Gandhi, Trials . 2014,第1期

机译：万古霉素与达托霉素治疗因高万古霉素最低抑菌浓度而引起的耐甲氧西林金黄色葡萄球菌菌血症的治疗：IIB期随机对照试验的研究方案
3. Plasma concentrations of second-line antituberculosis drugs in relation to minimum inhibitory concentrations in multidrug-resistant tuberculosis patients in China: a study protocol of a prospective observational cohort study [J] . Lina Davies Forsman, Katarina Niward, Yi Hu, BMJ Open . 2018,第9期

机译：中国多药耐药结核病患者二线抗结核药物的血浆浓度与最低抑菌浓度的关系：一项前瞻性观察性队列研究的研究方案
4. MINIMUM INHIBITORY CONCENTRATIONS FOR CEFTIOFUR AND COMPARATOR ANTIMICROBIAL AGENTS AGAINST BOVINE MASTITIS PATHOGENS ISOLATED FROM 2001 TO 2003 IN THE UNITED STATES AND CANADA [C] . Cindy J. Lindeman, Ellen S. Portis, Lacie A. Johansen Annual Meeting of the National Mastitis Council . 2005

机译：头孢噻呋和比较剂抗菌药物对2001年至2003年牛乳腺炎病原体的最低抑制浓度和比较牛乳腺炎病原体和加拿大
5. The minimum inhibitory concentration and mode of action of decanol against Listeria monocytogenes and its antilisterial effects in ready-to-eat meat products. [D] . Elgaali, Hesham Abd-Alrahim. 2005

机译：癸醇对单核细胞增生李斯特氏菌的最小抑制浓度和作用方式及其在即食肉制品中的抗李斯特菌作用。
6. A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations – results of a prematurely terminated study [O] . Shirin Kalimuddin, Yvonne F. Z. Chan, Rachel Phillips, 2018

机译：万古霉素与达托霉素的随机2B期临床试验用于治疗耐甲氧西林的金黄色葡萄球菌菌血症因为该菌株具有高的万古霉素最低抑菌浓度–一项提前终止的研究结果
7. Vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations: study protocol for a phase IIB randomized controlled trial [O] . Shirin Kalimuddin, Rachel Phillips, Mihir Gandhi, 2014

机译：万古霉素与达托霉素治疗因高万古霉素最低抑菌浓度而引起的耐甲氧西林金黄色葡萄球菌菌血症的治疗：IIB期随机对照试验的研究方案

1266. Characterization of Shifts in Minimum Inhibitory Concentrations During Treatment with Cefiderocol or Comparators in the Phase 3 CREDIBLE-CR and APEKS-NP Studies

摘要

著录项

相似文献

相关主题

期刊订阅